Up a level |
Journal Article
Benza, Raymond L., Corris, Paul A., Klinger, James R., Langleben, David, Naeije, Robert, Simonneau, Gerald, Ghofrani, Hossein-Ardeschir, Jansa, Pavel ORCID: 0000-0002-3711-7064, Rosenkranz, Stephan, Scelsi, Laura, Thenappan, Thenappan ORCID: 0000-0002-6210-0467, Raina, Amresh, Meier, Christian, Busse, Dennis and Hoeper, Marius M. (2020). Identifying potential parameters associated with response to switching from a PDE5i to riociguat in RESPITE. Int. J. Cardiol., 317. S. 188 - 193. CLARE: ELSEVIER IRELAND LTD. ISSN 1874-1754
Benza, Raymond L., Farber, Harrison W., Frost, Adaani, Ghofrani, Hossein-Ardeschir, Gomez-Sanchez, Miguel A., Langleben, David, Rosenkranz, Stephan, Busse, Dennis, Meier, Christian, Nikkho, Sylvia and Hoeper, Marius M. (2018). REVEAL risk scores applied to riociguat-treated patients in PATENT-2: Impact of changes in risk score on survival. J. Heart Lung Transplant., 37 (4). S. 513 - 520. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1557-3117
Benza, Raymond L., Langleben, David, Hemnes, Anna R., Noordegraaf, Anton Vonk, Rosenkranz, Stephan, Thenappan, Thenappan ORCID: 0000-0002-6210-0467, Hassoun, Paul M., Preston, Ioana R., Ghio, Stefano, Badagliacca, Roberto, Vizza, Carmine D., Lang, Irene M., Meier, Christian and Gruenig, Ekkehard (2022). Riociguat and the right ventricle in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. Eur. Respir. Rev., 31 (166). SHEFFIELD: EUROPEAN RESPIRATORY SOC JOURNALS LTD. ISSN 1600-0617
Hoeper, Marius M., Al-Hiti, Hikmet, Benza, Raymond L., Chang, Sung-A, Corris, Paul A., Gibbs, J. Simon R., Grunig, Ekkehard, Jansa, Pavel ORCID: 0000-0002-3711-7064, Klinger, James R., Langleben, David, McLaughlin, Vallerie V., Meyer, Gisela M. B., Ota-Arakaki, Jaquelina, Peacock, Andrew J., Pulido, Tomas, Rosenkranz, Stephan, Vizza, Carmine Dario ORCID: 0000-0002-3540-4983, Vonk-Noordegraaf, Anton, White, R. James, Chang, Mikyung, Kleinjung, Frank, Meier, Christian, Paraschin, Karen, Ghofrani, Hossein Ardeschir and Simonneau, Gerald (2021). Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial. Lancet Resp. Med., 9 (6). S. 573 - 585. OXFORD: ELSEVIER SCI LTD. ISSN 2213-2600
Hoeper, Marius M., Simonneau, Gerald, Corris, Paul A., Ghofrani, Hossein-Ardeschir, Klinger, James R., Langleben, David, Naeije, Robert, Jansa, Pavel ORCID: 0000-0002-3711-7064, Rosenkranz, Stephan, Scelsi, Laura ORCID: 0000-0001-9409-691X, Gruenig, Ekkehard, Vizza, Carmine Dario, Chang, MiKyung, Colorado, Pablo, Meier, Christian, Busse, Dennis and Benza, Raymond L. (2017). RESPITE: switching to riociguat in pulmonary arterial hypertension patients with inadequate response to phosphodiesterase-5 inhibitors. Eur. Resp. J., 50 (3). SHEFFIELD: EUROPEAN RESPIRATORY SOC JOURNALS LTD. ISSN 1399-3003
Klinger, James R., Benza, Raymond L., Chang, Sung-A, Ghofrani, Hossein-Ardeschir, Hoeper, Marius M., Jansa, Pavel, Ota-Arakaki, Jaquelina, Rosenkranz, Stephan, Simonneau, Gerald, Vizza, Carmine Dario ORCID: 0000-0002-3540-4983, Vonk-Noordegraaf, Anton and Mclaughlin, Vallerie (2021). Switching from PDE5i to riociguat in patients with PAH: A responder analysis from REPLACE. Eur. Resp. J., 58. SHEFFIELD: EUROPEAN RESPIRATORY SOC JOURNALS LTD. ISSN 1399-3003
McGoon, Michael D., Benza, Raymond L., Escribano-Subias, Pilar, Jiang, Xin, Miller, Dave P., Peacock, Andrew J., Pepke-Zaba, Joanna, Pulido, Tomas, Rich, Stuart, Rosenkranz, Stephan, Suissa, Samy and Humbert, Marc ORCID: 0000-0003-0703-2892 (2013). Pulmonary Arterial Hypertension Epidemiology and Registries. J. Am. Coll. Cardiol., 62 (25). S. D51 - 9. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1558-3597
Simonneau, Gerald, Ghofrani, Hossein-Ardeschir, Corris, Paul A., Rosenkranz, Stephan, Gruenig, Ekkehard, White, Jim, McLaughlin, Vallerie V., Langleben, David, Meier, Christian, Busse, Dennis, Kleinjung, Frank and Benza, Raymond L. (2020). Assessment of the REPLACE study composite endpoint in riociguat-treated patients in the PATENT study. Pulm. Circ., 10 (4). THOUSAND OAKS: SAGE PUBLICATIONS INC. ISSN 2045-8940